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Abstract
Background: Whilst there is much current data on early outcomes after Coronary artery bypass
grafting(CABG), there is relatively little data on medium term outcomes in the current era. The
purpose of this study is to present a single surgeon series comprising of all first time CABG patients
operated on with the technique of cross clamp fibrillation from Feb-1996 to through to Jan-2003,
and to seek risk factors for medium term mortality in these patients.
Methods:  Data was collected from Hospital Episode Statistics and departmental patient
administration and tracking systems and cross checked using database techniques. Patient
outcomes were searched using the National Health Service strategic tracing service.
Results: Mean follow up was 5.3 years(0–9.4 years) and was complete for all patients. 30-day
survival was 98.4%, 1-year survival 95% and 8-year survival 79%. Cox-regression analysis revealed
that several modifiable pre-operative risk factors remain significant predictors of medium term
mortality, including Diabetes(Hazard Ratio(HR) 1.73, 95%CI 1.21–2.45), Chromic obstructive
pulmonary disease(HR 2.02, 95%CI 1.09–3.72), Peripheral vascular disease(HR 1.68, 95%CI
1.13–2.5), Body mass index>30(HR 1.54, 95%CI 1.08–2.20) and current smoker at operation(HR
1.67, 95%CI 1.03–2.72). However hypertension(HR 1.31, 95%CI 0.95–1.82) and
Hypercholestrolaemia(HR 0.81, 95%CI 0.58–1.13) were not predictive which may reflect adequate
post-operative control.
Conclusion: Coronary artery bypass surgery using cross clamp fibrillation is associated with a very
low operative mortality. Medium term survival is also good but risk factors such as smoking at
operation, Chronic obstructive pulmonary disease, obesity and diabetes negatively impact this
survival and should be aggressively treated in the years post-surgery.
Introduction
The ultimate aim of coronary artery bypass grafting is to
achieve long term patency of coronary bypass grafts and
therefore long term symptom free survival. Therefore
every technique of bypass grafting should be judged by
these outcome measures. Many studies have been per-
formed to assess the long term survival in patients under-
going coronary surgery using cardioplegic on-pump
surgery[1-4] and also off-pump bypass grafting [5-7].
Indeed a recent statement from the American Heart Asso-
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ciation compared the long term outcomes between the
two techniques[8]. However there have been no studies
reporting the long-term survival of patients undergoing
coronary arterial bypass grafting using cross clamp fibril-
lation. Benefits of this technique include very short cross-
clamp and bypass times, whilst consistently achieving
complete revascularisation. This technique is used by 15%
of UK surgeons [9-11]which equates to around 3500
operations in the UK per year. Thus we sought to assess
the medium to long term survival of patients undergoing
bypass grafting using cross-clamp fibrillation. Our second
aim was to identify risk factors for long term mortality for
these patients. Our hypothesis was that we may be able to
identify risk factors pre-operatively that may be amenable
to modification in the years post surgery, thereby further
improving long term survival.
Methods
Surgical techniques
This has been previously described[11]. The heart is
approached through a median sternotomy and the left
Internal Mammary Artery harvested on a broad pedicle.
Papaverine is topically applied. The saphenous vein is
routinely used for subsequent grafts unless they are not
suitable for harvesting in which case a radial artery or sec-
ond mammary artery would be used. The patient is placed
on cardiopulmonary bypass and the aorta cross-clamped
while each distal anastomosis is fashioned. The cross
clamp is then removed while the proximal anastomosis is
formed. Bypass is performed at 32 degrees centigrade, and
pulmonary artery venting is not routinely used.
Data Management
Local Ethics Board Approval was obtained to utilise our
own database for this study and also to obtain survival sta-
tistics for each of the patients on our database. All data
was prospectively collected on the departmental Patient
Access and Tracking System (PATS) (Dendrite). Survival
data is available for all residents of England through the
National Health Service Strategic Tracing Service, using
the patients NHS number as a unique identifier. This was
accessed using an Internet based, password secured
approach.
Urgent patients were defined as any patient requiring their
operation prior to hospital discharge. This included a
small number of patients having their operation within
24 hours or referral. A good left ventricular ejection frac-
tion (EF) was defined as an ejection fraction over 50%,
moderate EF 30–50% and poor EF >30%.
Statistics
Statistical analysis was performed on SPSS 13.0. Binomial
categorical data was compared using the Fisher's test, and
the remaining categorical variables were analysed using
the Chi-Squared test. Continuous data was analysed using
the unpaired T-test if normality could be established, and
skewed or rank data was analysed using the Mann Whit-
ney U test. Multivariate analysis was performed using Cox
regression and all variables that demonstrated a univariate
significant predictive ability for mortality to a p-value <0.2
were entered into the model. Of note parsonnet score was
not entered into the multivariate analysis as it is a com-
posite score of multiple potential univariate predictors,
and may thus mask their predictive ability.
Results
From Feb 1996 to through to Jan 2003, a total of 1177
patients were identified as having either elective or urgent
first time isolated CABG. 80% (939/1177) of patients
were male and mean age was 63 years (Standard Devia-
tion(SD) 9.7 years). 73% had triple vessel disease, 22%
had double vessel disease and 5% had single vessel dis-
ease. 17% had left main stem disease. Mean number of
grafts was 3.24 (Range 1–6). Mean follow up was 5.3 years
(range 0–9.4 years, minimum follow up of living patients
was 892 days). The full demographics for this study are
shown in table 1 together with their ability to predict
medium term mortality.
Average cross clamp time was 27 minutes (SD 11.7) and
mean bypass time was 67 minutes (SD 25). The short
term complication rate was low (Table 2). The IABP usage
was 1.4% (17/1177 patients), Inotropes were used in 14%
(167/1177 patients). The re-operation rate was 3.5% (35/
1177 patients) and the rate of sternal re-wiring was 0.7%
(8/1177 patients). The readmission to ICU rate was 2%
(23/1177 patients). The 30 day mortality was 1.6% (19
patients).
Mean follow up was 5.3 years and the 5-year survival was
86%. Follow up was performed up to 9 years and the sur-
vival at this stage was 79% across the whole group. This
survival was significantly dependant on both age and par-
sonnet score as might be expected (Figures 1 and 2). Sur-
vival at 8 years for the various age categories were: under
55 years: 91%, 55–65 years: 83%, 65–75 years: 74%, over
75 years: 45%.
Our survival compared well with the UK survival rates of
healthy residents of our region supplied by the Office of
National Statistics. For example the 9 years survival of a
healthy 63 year old in our region was 83%, and in our
study our 9 year survival was 79% (Our mean age is 63 in
our database)
We analysed the database for significant medium term
predictors of mortality (Table 3). We found that several
modifiable pre-operative risk factors persisted as post-
operative risk factors. The presence of any type of diabetesJournal of Cardiothoracic Surgery 2007, 2:51 http://www.cardiothoracicsurgery.org/content/2/1/51
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significantly predicted adverse medium term mortality
(Odds ratio(OR) 1.73, 95%CI 1.21–2.45). Also presence
of chronic obstructive pulmonary disease predicted
medium term mortality (Hazard Ratio(HR) 2.02, 95%CI
1.09–3.72), peripheral vascular disease predicted medium
term mortality (HR 1.68, 95%CI 1.13–2.5) and a Body
Mass Index(BMI) of over 30 predicted mortality(HR 1.54,
95%CI 1.08–2.20). Current smoker at operation (HR
1.67, 95%CI 1.03–2.72) also predicted medium term
mortality. However hypertension (HR 1.31, 95%CI
0.95–1.82) and Hypercholestrolaemia (HR 0.81, 95%CI
0.58–1.13) failed to reach significance.
Comment
We have demonstrated that coronary arterial bypass graft-
ing using cross-clamp fibrillation is associated with low
short and medium term mortality. Furthermore we have
demonstrated that in the years post-cardiac surgery, mod-
Table 2: Post operative complications
Total (N = 1177) Survivors (N = 1018) Non-long term Survivor (N = 159) P-value
IABP 14 (1.2%) 8 (0.8%) 6 (3.8%) P = 0.001
Inotropes 167 (14%) 138 (14%) 29 (18%) P = 0.001
Atrial Fibrillation 236 (20%) 202 (20%) 34 (21%) P = 0.670
Blood given post-op 217 (19%) 164 (16%) 53 (34%) P < 0.0005
Blood loss post-op (SD) 821 mls (566) 820 mls (552) 831 mls(650) P = 0.829
Re-operation 35 (3%) 23 (2.3%) 12 (7.5%) P = 0.001
Sternal resuturing 8 (0.7%) 2 (0.2%) 6 (3.8%) P < 0.0005
Parsonnet (SD) 6.2 (6.2) 5.7 (5.9) 9.8 (7.0) P < 0.0005
Renal Failure 51 (4.3%) 28 (2.8%) 23 (15%) P < 0.0005
Reintubation 11 (0.9%) 6 (0.6%) 5 (3.1%) P = 0.010
ICU readmission 23 (2%) 11 (1.1%) 12 (7.5%) P < 0.0005
Table 1: Study Demographics
Total (N = 1177) Survivors (N = 1018) Non-long term Survivor (N = 159) P-value
Male (%) 939 (80%) 823(81%) 116 (73%) P = 0.026
female (%) 238 (20%) 195(19%) 43 (27%)
Age Mean (SD) 63 years (9.7) 62 (9.6) 68 (9.8) P < 0.0001
CCS I 124 (10%) 107 (11%) 17 (11%) P = 0.01
II 335 (29%) 307 (30%) 28 (18%)
III 429 (36%) 373 (36%) 56 (35%)
IV 289 (25%) 231 (23%) 58 (36%)
Previous MI 552 (47%) 457 (45%) 95 (60%) P = 0.01
Prev Cardiological Intervention 87 (7.4%) 78 (7.7%) 9 (5.7%) P = 0.42
Diabetes 203 (17%) 162 (16%) 41 (26%) P = 0.003
Hypertension 573 (49%) 487 (48%) 86 (54%) P = 0.012
Hypercholestrolemia 843 (71%) 749 (74%) 94 (59%) P < 0.0005
Current smoker 73 (6.2%) 62 (6.1%) 11 (6.9%) P = 0.723
COPD 36 (3.1%) 23 (2.3%) 13 (8.2%) P < 0.0005
PVD 146 (12%) 110 (11%) 36 (23%) P < 0.0005
Coronary Disease
Single 56 (4.8%) 54 (5.3%) 2 (1.3%) P = 0.860
Double 258 (22%) 234 (23%) 24 (15%)
Triple 863 (73%) 730 (72%) 133 (84%)
LMS disease 202 (17%) 173 (17%) 29 (18%) P = 0.734
EF Good 777 (66%) 701 (69%) 76 (48%) P < 0.0005
Fair 308 (26%) 253 (25%) 55 (34%)
Poor 92 (8%) 64 (6%) 28 (18%)
Pre-op IABP 17 (1.4%) 11 (1.1%) 6 (3.8%) P = 0.019
No of distal anastomoses 3.24 (0.97) Range 1–6 3.24 (0.98) 3.26 (0.91) P = 0.844
Bypass time 67 mins (25) 66 mins (24) 75 mins (32) P = 0.002
X-Clamp time 27 mins (11) 27 mins (12) 27 mins (10) P = 0.769
BMI>30 307 (28%) 259 (27%) 48 (31%) P = 0.190
Trasylol 243 (21%) 210 (21% 33 (21%) P = 1.000Journal of Cardiothoracic Surgery 2007, 2:51 http://www.cardiothoracicsurgery.org/content/2/1/51
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ifiable risk factors remain a significant cause of mortality.
Hypertension and high cholesterol did not show a signif-
icant association in our database. This may be due to the
fact that these risk factors are now aggressively treated by
cardiologists and general practitioners in the years post
cardiac surgery. In the United Kingdom and internation-
ally, guidelines exist for the control of both hypertension
and cholesterol in the community and are regarded as
being well adhered to[12,13].
In contrast diabetes, peripheral vascular disease, a high
BMI, and current smoking all adversely affected long term
mortality. We hypothesise that these risk factors are not as
successfully treated in the years after cardiac surgery. It is
our experience that patients who smoke through their
admission for cardiac surgery invariably fail to stop smok-
ing in the immediate post operative period. In addition
patients with a high BMI also tend to fail to lose weight
post operatively. Peripheral vascular disease may reflect
patients with an aggressive atherosclerotic process in sev-
eral other organs in addition to the heart and thus the risk
of mortality due to other causes may be higher.
We have shown that diabetes remains a risk factor for late
mortality. Further studies would be required to determine
whether tighter glucose control would improve survival or
whether this effect reflects the poorer prognosis of
patients with diabetes although the association with
tighter glucose control and survival is well estab-
lished[14].
Gardner et al[15] performed a retrospective analysis of
11,815 patients undergoing coronary surgery in 43 US
hospitals, searching for risk factors for 6 month survival.
Their survival at 6 months was 93.8% and they found that
Table 3: Predictors of medium term mortality as determined by 
Cox Regression analysis
Hazard 
ratio
95.0% CI for Odds 
ratio
Sig.
Lower Upper
Diabetes 1.735 1.208 2.492 0.003
hypercholestrolaemia 0.808 0.575 1.133 0.217
Hypertension 1.317 0.953 1.821 0.096
Pre-op renal failure 5.125 2.512 10.458 <0.0005
COPD 2.017 1.094 3.718 0.025
Peripheral Vascular disease 1.677 1.127 2.495 0.011
EF 30–50% 1.483 1.026 2.143 0.036
EF <30% 2.141 1.316 3.483 0.002
BMI >30 1.540 1.079 2.198 0.017
Current smoker at 
operation
1.673 1.031 2.715 0.037
Age at operation 1.072 1.050 1.094 <0.0005
Kaplain-Meier Survival plot by Parsonnet score Figure 1
Kaplain-Meier Survival plot by Parsonnet score.
Kaplain-Meier survival plot by agegroup Figure 2
Kaplain-Meier survival plot by agegroup.Journal of Cardiothoracic Surgery 2007, 2:51 http://www.cardiothoracicsurgery.org/content/2/1/51
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Chronic Obstructive Pulmonary disease (COPD), cere-
brovascular disease and older age predicted 6 month mor-
tality.
Boucher et al [16] studied 329 patients over 70 years of
age after cardiac surgery. They reported a 9.4% operative
mortality and thereafter a 5-year survival of 86% which
was comparable with the background population in their
area. Their survival was comparable to that in our own
study.
Caputo et al [17] reported the medium term survival of
1,479 patients who had undergone off-pump coronary
arterial revascularisation. They reported a 2 year mortality
of 4.7% in patients who received a complete revasculari-
sation. Of note they found a 10.8% 2 year mortality in
patients who received an incomplete revascularisation.
Our 2 year survival is therefore comparable to this cohort
of patients operated on with off pump surgery with com-
plete revascularization.
The Multicenter Study of Perioperative Ischemia Research
Group[18] found in an analysis of 2,048 patients from 24
centres that the 5 year survival was adversely impacted by
age, diabetes, congestive heart failure and anaemia, in
agreement with our own results.
Gao et al [4] analysed 56,543 patients who underwent
CABG at one of 43 veterans hospitals for risk factors for
long term survival. They found that diabetes had an
increasing impact on survival, eventually doubling mor-
tality at 9 years post-operatively. They also found that
COPD, age and urgent surgery persisted as a risk factor in
the years post surgery in agreement with our results. Their
5 year survival was 81% in their cohort of patients with
the same mean age as our own.
The CASS registry followed up their cohort of 24,959
patients who underwent coronary artery bypass grafting
between 1974 and 1979[2]. Their 10-year survival was
74% in this cohort of patients who had a mean age of
under 55. They identified that risk factors for long term
survival included heavier weight, diuretic use, diabetes
and smoking. They did not investigate peripheral vascular
disease as a risk factor.
Our study has weaknesses. It is retrospective in nature
although our follow up is complete due to the fact that the
NHS tracing service contains a complete database of all
deaths in the UK. We have not yet been able to obtain data
on the cause of death for our post-operative patients. In
addition we have no information as to the incidence of
MI, stroke or reintervention in the years post surgery. This
data could potentially provide valuable additional evi-
dence in support of the fact that modifiable risk factors
may account for a large proportion of the deaths. This
series is a single surgeon's series, and although this elimi-
nates a large amount of perioperative technical heteroge-
neity associated with other studies, the presence of
modifiable risk factors in other surgeons practice would
require confirmation. Also we have not provided a
detailed account of radial artery or RIMA usage although
in our experience this usage was very low in this database.
It is possible that long term outcomes may have been
superior with arterial conduit usage although the RAPCO
randomised study of saphenous vein versus arterial con-
duits has so far shown no benefit at 5 years after randomi-
zation [19]
We conclude that the treatment of coronary atheroscle-
rotic disease by cardiothoracic surgeons should not end
on successful discharge from the unit. The cardiothoracic
surgeons should ensure that the patient is placed into pro-
grammes of smoking cessation, weight loss and diabetes
supervision as appropriate. Cardiac Surgeons should
ensure that these programmes are effective in their area
and ensure that regular audits of their efficacy are con-
ducted.
We have furthermore demonstrated that coronary arterial
bypass grafting using cross clamp fibrillation is associated
with an equivalent short and medium term survival to
patients undergoing coronary revascularization either
using cardioplegia or off-pump techniques.
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